Pro PG receives S19 A for Bleomycin Injection (market shortage Australia) - stock available now.
Pro Pharmaceuticals Group has received the Section 19A approval for supply of Bleomycin Injection until January 31st 2020.
Bleomycin Injection is currently experiencing a shortage of supply in Australia.
Product: Bleomycin Injection 15 Units S19a
Stock availability: Stock is available now at Wholesalers Nationally.
Orders can be placed via Wholesalers Symbion and Central Healthcare Services (CHS) via the below PDE numbers.
Symbion PDE: 629103
CHS PDE: BLEI15PR